Enzo Life Sciences Screen-Well FDA v 2.0 Approved Drug Library

Thursday, 14 November, 2013 | Supplied by: United Bioresearch Products Pty Ltd

Drug repositioning or repurposing can be an important part of any drug discovery program. The Enzo Life Sciences Screen-Well FDA-approved drug library has been revised to provide over 100 more compounds, including recent FDA-approved drugs, making it a complete option for drug repurposing screens.

Being FDA approved and in use in clinics, all of the compounds in the drug library have known and well-characterised bioactivity, safety and bioavailability for diverse targets - properties which could dramatically accelerate drug development and optimisation. Its diverse compounds are approved for cardiovascular, neuropsychological, immunological, oncological and other uses.

The library avoids irrelevant compounds found in similar libraries, such as herbicides, insecticides, sunscreen agents and cytotoxic agents. Comprehensive documentation includes a compound list and SD files with indication and mechanism of action. Many of the compounds included can also be provided as stand-alone compounds for further testing.

The set provides a rich source of bioactives and is claimed to offer the greatest degree of drug likeness available.

Online: www.unitedbioresearch.com.au
Phone: 02 4575 0309
Related Products

Cayman Chemical Total Iron-Binding Capacity (TIBC) and Serum Iron Assay Kit

Cayman Chemical's Total Iron-Binding Capacity (TIBC) and Serum Iron Assay Kit provides a...

Sphere Fluidics Cyto-Mine single-cell analysis system for cell line development

Sphere Fluidics' Cyto-Mine is a single-cell analysis platform that enables individual cells...

Bio-Rad Laboratories CFX Opus Deepwell Real-Time PCR Detection System

Bio-Rad Laboratories has launched the CFX Opus Deepwell Real-Time PCR Detection System to support...

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd